Patents by Inventor Daniel Kolk

Daniel Kolk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12497655
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovinis nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Grant
    Filed: June 7, 2022
    Date of Patent: December 16, 2025
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Mehrdad R. Majlessi, Ankur Shah, Amber Hillius, Pamela Douglass, Daniel Kolk
  • Patent number: 12460255
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Grant
    Filed: December 27, 2022
    Date of Patent: November 4, 2025
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Mehrdad R. Majlessi, Ankur Shah, Amber Hillius, Pamela Douglass, Daniel Kolk
  • Patent number: 12428672
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Grant
    Filed: February 15, 2024
    Date of Patent: September 30, 2025
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Mehrdad Majlessi, Pamela Douglass, Daniel Kolk
  • Patent number: 12404541
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Grant
    Filed: February 15, 2024
    Date of Patent: September 2, 2025
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Mehrdad Majlessi, Pamela Douglass, Daniel Kolk
  • Patent number: 12398420
    Abstract: The disclosure is related to compositions, for targeting Adenovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers.
    Type: Grant
    Filed: December 27, 2022
    Date of Patent: August 26, 2025
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Mehrdad R. Majlessi, Ankur Shah, Amber Hillius, Pamela Douglass, Daniel Kolk
  • Patent number: 12338491
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Rhinovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Grant
    Filed: August 17, 2022
    Date of Patent: June 24, 2025
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Mehrdad R. Majlessi, Ankur Shah, Amber Hillius, Pamela Douglass, Daniel Kolk
  • Patent number: 12116620
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: October 15, 2024
    Assignee: Gen-Probe Incorporated
    Inventors: Mehrdad Majlessi, Pamela Douglass, Daniel Kolk
  • Publication number: 20240318230
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Application
    Filed: February 15, 2024
    Publication date: September 26, 2024
    Applicant: Gen-Probe Incorporated
    Inventors: Mehrdad MAJLESSI, Pamela DOUGLASS, Daniel KOLK
  • Publication number: 20240318231
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Application
    Filed: February 15, 2024
    Publication date: September 26, 2024
    Applicant: Gen-Probe Incorporated
    Inventors: Mehrdad MAJLESSI, Pamela DOUGLASS, Daniel KOLK
  • Publication number: 20240309429
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Application
    Filed: February 15, 2024
    Publication date: September 19, 2024
    Applicant: Gen-Probe Incorporated
    Inventors: Mehrdad MAJLESSI, Pamela DOUGLASS, Daniel KOLK
  • Publication number: 20230203572
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Application
    Filed: December 27, 2022
    Publication date: June 29, 2023
    Inventors: Mehrdad R. MAJLESSI, Ankur SHAH, Amber HILLIUS, Pamela DOUGLASS, Daniel KOLK
  • Publication number: 20230203571
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Application
    Filed: December 27, 2022
    Publication date: June 29, 2023
    Inventors: Mehrdad R. MAJLESSI, Ankur SHAH, Amber HILLIUS, Pamela DOUGLASS, Daniel KOLK
  • Publication number: 20230087588
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Application
    Filed: August 17, 2022
    Publication date: March 23, 2023
    Inventors: Mehrdad R. MAJLESSI, Ankur Shah, Amber Hillius, Pamela Douglass, Daniel Kolk
  • Publication number: 20220372563
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovinis nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Application
    Filed: June 7, 2022
    Publication date: November 24, 2022
    Inventors: Mehrdad R. MAJLESSI, Ankur SHAH, Amber HILLIUS, Pamela DOUGLASS, Daniel KOLK
  • Patent number: 11384387
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: July 12, 2022
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Mehrdad R. Majlessi, Ankur Shah, Amber Hillius, Pamela Douglass, Daniel Kolk
  • Publication number: 20210040541
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Application
    Filed: October 16, 2020
    Publication date: February 11, 2021
    Applicant: Gen-Probe Incorporated
    Inventors: Mehrdad Majlessi, Pamela Douglass, Daniel Kolk
  • Patent number: 10844425
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: November 24, 2020
    Assignee: Gen-Probe Incorporated
    Inventors: Mehrdad Majlessi, Pamela Douglass, Daniel Kolk
  • Publication number: 20200263242
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Application
    Filed: March 23, 2018
    Publication date: August 20, 2020
    Applicant: GEN-PROBE INCORPORATED
    Inventors: Mehrdad R. MAJLESSI, Ankur SHAH, Amber HILLIUS, Pamela DOUGLASS, Daniel KOLK
  • Publication number: 20180274012
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Application
    Filed: March 23, 2018
    Publication date: September 27, 2018
    Applicant: Gen-Probe Incorporated
    Inventors: Mehrdad Majlessi, Pamela Douglass, Daniel Kolk
  • Publication number: 20080081328
    Abstract: Compositions, methods and kits for detecting viral nucleic acids. Targets that can be detected in accordance with the invention include HBV and/or HIV-1 and/or HCV nucleic acids. Particularly described are oligonucleotides that are useful as hybridization probes and amplification primers that facilitate detection of very low levels of HBV nucleic acids.
    Type: Application
    Filed: October 15, 2007
    Publication date: April 3, 2008
    Applicant: GEN-PROBE INCORPORATED
    Inventors: Jeffrey LINNEN, Daniel KOLK, Janel DOCKTER, Damon GETMAN, Tadashi YOSHIMURA, Martha HO-SING-LOY, Reinhold POLLNER, Leslie STRINGFELLOW